Structure-based molecular hybridization design of Keap1-Nrf2 inhibitors as novel protective agents of acute lung injury
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structure-based molecular hybridization design of Keap1-Nrf2 inhibitors as novel protective agents of acute lung injury
Authors
Keywords
Molecular hybridization, Keap1-Nrf2, Acute lung injury, Protein-protein interaction, Naphthalensulfonamides, Anti-inflammation
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 222, Issue -, Pages 113599
Publisher
Elsevier BV
Online
2021-06-05
DOI
10.1016/j.ejmech.2021.113599
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recapitulating the Binding Affinity of Nrf2 for KEAP1 in a Cyclic Heptapeptide, Guided by NMR, X-ray Crystallography, and Machine Learning
- (2021) Paula C. Ortet et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent Compounds
- (2021) Jakob S. Pallesen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Emerging Substrate Proteins of Kelch-like ECH Associated Protein 1 (Keap1) and Potential Challenges for the Development of Small-Molecule Inhibitors of the Keap1-Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Protein–Protein Interaction
- (2020) Yong Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- An open-source drug discovery platform enables ultra-large virtual screens
- (2020) Christoph Gorgulla et al. NATURE
- Combined Peptide and Small-Molecule Approach toward Nonacidic THIQ Inhibitors of the KEAP1/NRF2 Interaction
- (2020) Jesus M. Ontoria et al. ACS Medicinal Chemistry Letters
- CDDO-Imidazolide Targets Multiple Amino Acid Residues on the Nrf2 Adaptor, Keap1
- (2020) Xiaoli Meng et al. JOURNAL OF MEDICINAL CHEMISTRY
- A hydrogen peroxide responsive prodrug of Keap1-Nrf2 inhibitor for improving oral absorption and selective activation in inflammatory conditions
- (2020) Mengchen Lu et al. Redox Biology
- Direct inhibition of Keap1-Nrf2 Protein-Protein interaction as a potential therapeutic strategy for Alzheimer's disease
- (2020) Yi Sun et al. BIOORGANIC CHEMISTRY
- Radiosensitization of human pancreatic cancer by piperlongumine analogues
- (2020) Hao Ma et al. CHINESE CHEMICAL LETTERS
- Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors
- (2020) Yi Mou et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Structure–Activity Relationships of Indoline-Based Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-Like 2 (Keap1-Nrf2) Protein–Protein Interaction Inhibitors
- (2020) Hai-Shan Zhou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivatives as potent KEAP1-NRF2 protein-protein interaction inhibitors for inflammatory conditions
- (2020) Meng-Chen Lu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of bardoxolone derivatives as novel orally active necroptosis inhibitors
- (2020) Yuanyuan Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
- (2019) Antonio Cuadrado et al. NATURE REVIEWS DRUG DISCOVERY
- CPUY192018, a potent inhibitor of the Keap1-Nrf2 protein-protein interaction, alleviates renal inflammation in mice by restricting oxidative stress and NF-κB activation
- (2019) Meng-Chen Lu et al. Redox Biology
- New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies
- (2019) Nehad A. El-Sayed et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Fragment-growing guided design of Keap1-Nrf2 protein-protein interaction inhibitors for targeting myocarditis
- (2018) Ning Meng et al. FREE RADICAL BIOLOGY AND MEDICINE
- Identification of a novel small-molecule Keap1–Nrf2 PPI inhibitor with cytoprotective effects on LPS-induced cardiomyopathy
- (2018) Cheng-Shi Jiang et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1–Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases
- (2018) Jakob S. Pallesen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis, in silico pharmacokinetics prediction and biological evaluation of 1,4-dihydroindeno[1,2-c]pyrazole chalcone as EGFR /Akt pathway inhibitors
- (2018) Irfan Khan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Small molecules inhibiting Keap1–Nrf2 protein–protein interactions: a novel approach to activate Nrf2 function
- (2017) Chunlin Zhuang et al. MedChemComm
- The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update
- (2016) Meng-Chen Lu et al. MEDICINAL RESEARCH REVIEWS
- Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
- (2016) Duncan E. Scott et al. NATURE REVIEWS DRUG DISCOVERY
- Updated Research and Applications of Small Molecule Inhibitors of Keap1-Nrf2 Protein-Protein Interaction: a Review
- (2014) Chunlin Zhuang et al. CURRENT MEDICINAL CHEMISTRY
- Rutin decreases lipopolysaccharide-induced acute lung injury via inhibition of oxidative stress and the MAPK–NF-κB pathway
- (2014) Chung-Hsin Yeh et al. FREE RADICAL BIOLOGY AND MEDICINE
- Rapid Identification of Keap1–Nrf2 Small-Molecule Inhibitors through Structure-Based Virtual Screening and Hit-Based Substructure Search
- (2014) Chunlin Zhuang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Keap Calm, and Carry on Covalently
- (2013) Anthony J. Wilson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice
- (2012) Xiaojun Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Acute Lung Injury Review
- (2009) Kenji Tsushima et al. INTERNAL MEDICINE
- Roles of Oxidants and Redox Signaling in the Pathogenesis of Acute Respiratory Distress Syndrome
- (2008) Sadatomo Tasaka et al. ANTIOXIDANTS & REDOX SIGNALING
- Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury
- (2008) Yumiko Imai et al. CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now